# Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases

Study · id `cardio:ct-nct06520774` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06520774](<https://clinicaltrials.gov/study/NCT06520774>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06520774

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 103 participants.

## Technical summary

Registry record NCT06520774. Allocation not applicable; no masking; primary purpose other. Start 2024-05-30 (actual); primary completion 2027-07-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 103 participants (planned count; ClinicalTrials.gov record NCT06520774, source copy `cardio:ctgov-nct06520774-2025-07-28`, retrieved 2026-11-18)
- Started: 2024-05-30 (actual) (ClinicalTrials.gov record NCT06520774, source copy `cardio:ctgov-nct06520774-2025-07-28`, retrieved 2026-11-18)
- Primary completion: 2027-07-30 (anticipated) (ClinicalTrials.gov record NCT06520774, source copy `cardio:ctgov-nct06520774-2025-07-28`, retrieved 2026-11-18)
- Completion: 2031-06-30 (anticipated) (ClinicalTrials.gov record NCT06520774, source copy `cardio:ctgov-nct06520774-2025-07-28`, retrieved 2026-11-18)
- Countries: China; Germany (ClinicalTrials.gov record NCT06520774, source copy `cardio:ctgov-nct06520774-2025-07-28`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06520774-2025-07-28`, retrieved 2026-11-18)

## The registry's words

- Brief title: Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases
- Condition: Aortic Arch Aneurysm
- Condition: Penetrating Aortic Ulcer
- Intervention (Device): Concave Supra-arch Branched Stent-Graft System
- Lead sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: Second Xiangya Hospital of Central South University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry condition terms include this condition: Thoracic aortic aneurysm (`cardio:thoracic-aortic-aneurysm`)
- Registry lists this organization as the lead sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. (`cardio:org-lifetech-scientific-shenzhen-co-ltd`)
- Registry lists this organization as a collaborator: Second Xiangya Hospital of Central South University (`cardio:org-second-xiangya-hospital-of-central-south-university`)

## Provenance

Content hash: ced9bb676c1725a61f05c7e6d55c568918431144951144e0c943b46cfd33b5ac
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
